Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Soligenix Inc SNGX

Healthcare Biotechnology
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the... see more

Current News (NDAQ:SNGX)

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

GlobeNewswire December 5, 2025

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space

GlobeNewswire December 3, 2025

Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte(TM) for the Treatment of Cutaneous T-Cell Lymphoma

PR Newswire November 19, 2025

Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results

PR Newswire November 7, 2025

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

PR Newswire October 14, 2025

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte(TM) for the Treatment of Cutaneous T-Cell Lymphoma

PR Newswire October 7, 2025

Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

PR Newswire September 30, 2025

Soligenix Announces Closing of $7.5 Million Public Offering

PR Newswire September 29, 2025

Soligenix Announces Pricing of $7.5 Million Public Offering

PR Newswire September 26, 2025
View More News ››

Opinion & Analysis (NDAQ:SNGX)

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs

Streetwise Reports August 22, 2019

NIH Selects Biopharma's Lead Asset for Commercialization Accelerator Program

Streetwise Reports September 27, 2018

Soligenix's diversified pipeline advances on all fronts

The Life Sciences Report August 31, 2016

VIDEO: Focused on Rare Disease Therapies

BTV-Business Television June 28, 2016

Soligenix develops defenses against bioterrorism SNGX

The Life Sciences Report June 15, 2016

Soligenix fosters potent pipeline of orphan disease compounds in areas of unmet medical need

The Life Sciences Report April 27, 2016
View More Opinion ››

Bullboard Posts (NDAQ:SNGX)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - October 7, 2025

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you fellas out there today anyway
coolfooldumbguy - August 18, 2025

Using technical analysis for this stock.

Break out to the upside today and it should do well for all of us shareholders here today
coolfooldumbguy - August 4, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway
coolfooldumbguy - July 31, 2025

SGNX WHO Says Risk of Marburg Virus Outbreak

SGNX WHO Says Risk of Marburg Virus Outbreak Very High at National Level
10QKing - October 3, 2024

Soligenix, Inc. (NASDAQ:SNGX): Positive Interim Results for

http://beyondspx.com/2024/08/02/soligenix-inc-nasdaqsngx-positive-interim-results-for-hybryte-in-investigator-initiated-study-in-ctcl...
MikeTester - August 3, 2024
View more Bullboard ››

Equity Metals Corp.

Equity Metals Corp.

Equity Metals Corporation engages in the acquisition, exploration, and development of mineral and diamond properties in ...
View More »

Podcasts